These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 21264260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 3. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M, Lotfi AS, Amani J, Eskandari K, Ramandi MF, Salimian J, Brujeni GN, Alamian S, Kamali M, Koushki H.
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [Abstract] [Full Text] [Related]

  • 4. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.
    Pasquevich KA, García Samartino C, Coria LM, Estein SM, Zwerdling A, Ibañez AE, Barrionuevo P, Oliveira FS, Carvalho NB, Borkowski J, Oliveira SC, Warzecha H, Giambartolomei GH, Cassataro J.
    J Immunol; 2010 May 01; 184(9):5200-12. PubMed ID: 20351187
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection.
    Wang H, Hoffman C, Yang X, Clapp B, Pascual DW.
    PLoS Pathog; 2020 Jan 01; 16(1):e1008176. PubMed ID: 31951645
    [Abstract] [Full Text] [Related]

  • 8. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model.
    Senevirathne A, Hewawaduge C, Lee JH.
    Vet Immunol Immunopathol; 2019 Mar 01; 209():31-36. PubMed ID: 30885303
    [Abstract] [Full Text] [Related]

  • 9. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
    Solanki KS, Varshney R, Qureshi S, Thomas P, Singh R, Agrawal A, Chaudhuri P.
    Int Immunopharmacol; 2021 Jan 01; 90():107148. PubMed ID: 33189614
    [Abstract] [Full Text] [Related]

  • 10. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S, Peddayelachagiri BV, Nagaraj S, Kingston JJ, Batra HV.
    Mol Immunol; 2018 Jul 01; 99():9-18. PubMed ID: 29649688
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge.
    Coria LM, Ibañez AE, Pasquevich KA, Cobiello PLG, Frank FM, Giambartolomei GH, Cassataro J.
    Vaccine; 2016 Jan 20; 34(4):430-437. PubMed ID: 26707377
    [Abstract] [Full Text] [Related]

  • 13. Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308.
    Dabral N, Martha-Moreno-Lafont, Sriranganathan N, Vemulapalli R.
    PLoS One; 2014 Jan 20; 9(9):e107180. PubMed ID: 25225910
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH.
    Infect Immun; 2005 Dec 20; 73(12):8079-88. PubMed ID: 16299302
    [Abstract] [Full Text] [Related]

  • 15. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.
    de Souza Filho JA, de Paulo Martins V, Campos PC, Alves-Silva J, Santos NV, de Oliveira FS, Menezes GB, Azevedo V, Cravero SL, Oliveira SC.
    Infect Immun; 2015 Apr 20; 83(4):1458-64. PubMed ID: 25644010
    [Abstract] [Full Text] [Related]

  • 16. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
    Goel D, Rajendran V, Ghosh PC, Bhatnagar R.
    Vaccine; 2013 Feb 06; 31(8):1231-7. PubMed ID: 23273966
    [Abstract] [Full Text] [Related]

  • 17. Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.
    Clapp B, Skyberg JA, Yang X, Thornburg T, Walters N, Pascual DW.
    Infect Immun; 2011 Oct 06; 79(10):4165-74. PubMed ID: 21768283
    [Abstract] [Full Text] [Related]

  • 18. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
    Paul S, Peddayelachagiri BV, Nagaraj S, Konduru B, Batra HV.
    Appl Microbiol Biotechnol; 2018 Oct 06; 102(20):8895-8907. PubMed ID: 30136204
    [Abstract] [Full Text] [Related]

  • 19. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT, Arayan LT, Huy TXN, Reyes AWB, Min W, Lee HJ, Park SJ, Chang HH, Kim S.
    Vaccine; 2018 May 17; 36(21):3027-3033. PubMed ID: 29678458
    [Abstract] [Full Text] [Related]

  • 20. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
    Tabynov K, Sansyzbay A, Kydyrbayev Z, Yespembetov B, Ryskeldinova S, Zinina N, Assanzhanova N, Sultankulova K, Sandybayev N, Khairullin B, Kuznetsova I, Ferko B, Egorov A.
    Virol J; 2014 Apr 10; 11():69. PubMed ID: 24716528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.